Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2003
11/06/2003US20030206890 Insect cells utilized that may be transformed with an expression system and thus proteins may be introduced into the composition through direct protein expression by the cells.
11/06/2003US20030206885 Vaccine immunotherapy for immune suppressed patients
11/06/2003US20030206861 Uses of diterpenoid triepoxides as an antiproliferative agent
11/06/2003US20030206857 Preparation and use of radium-223 to target calcified tissues for pain palliation, bone cancer therapy, and bone surface conditioning
11/06/2003CA2484546A1 Methods and compositions for treatment of cancer pain
11/06/2003CA2484067A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/06/2003CA2483819A1 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus
11/06/2003CA2483636A1 3,4-dihydroquinolin-2(1h)-one compounds as nr2b receptor antagonists
11/06/2003CA2483557A1 Methods and compositions for treating, preventing or delaying onset of a neoplasm
11/06/2003CA2483515A1 Novel thiol derivative, method for producing the same and use thereof
11/06/2003CA2483505A1 Circular dumbbell decoy oligodeoxynucleotides (cdodn) containing dna bindings sites of transcription
11/06/2003CA2483500A1 Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
11/06/2003CA2483496A1 Inhibitors of checkpoint kinases (wee1 and chk1)
11/06/2003CA2483468A1 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process
11/06/2003CA2483449A1 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
11/06/2003CA2483441A1 Mannose binding lectin and uses thereof
11/06/2003CA2483340A1 Synergistic effects of nuclear transcription factor nf-.kappa.b inhibitors and anti-neoplastic agents
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003CA2483253A1 Use of compounds having ccr antagonism
11/06/2003CA2483091A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo' b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
11/06/2003CA2483075A1 Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors
11/06/2003CA2482941A1 Microparticle pharmaceutical compositions for intratumoral delivery
11/06/2003CA2482930A1 Epha2 antigen t epitopes
11/06/2003CA2482455A1 1,2,3,4,7,8-hexahydro-6h-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
11/06/2003CA2481324A1 [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents
11/06/2003CA2480845A1 Adipocyte complement related protein zacrp8
11/06/2003CA2480497A1 Substituted pyrazine derivatives
11/06/2003CA2480092A1 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/05/2003EP1359215A1 Soya cell strains with high isoflavone content
11/05/2003EP1359156A2 Papilloma virus vaccine
11/05/2003EP1358910A1 Methods and means for prevention, inhibition and therapy of cancer
11/05/2003EP1358888A1 The human peptide antibiotic LL-37/hCAP-18 is an inducer of angiogenesis
11/05/2003EP1358353A2 Identification of genetic determinants of polymorphic cyp3a5 expression
11/05/2003EP1358336A2 Human serine-threonine kinase
11/05/2003EP1358332A2 A serpin in bifidobacteria
11/05/2003EP1358329A2 Lipid-associated molecules
11/05/2003EP1358328A2 Regulation of human serotonin-like g protein-coupled recepter
11/05/2003EP1358327A2 Proteins and nucleic acids encoding same
11/05/2003EP1358326A2 Proteins associated with cell growth, differentiation, and death
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358320A2 68730 and 69112 protein kinase molecules and uses therefor
11/05/2003EP1358318A2 Hybridoma cell line g250 and its use for producing monoclonal antibodies
11/05/2003EP1358206A2 Peptide-based compounds
11/05/2003EP1358203A2 Methods and compositions for use in spliceosome mediated rna trans-splicing
11/05/2003EP1358187A2 Naphthyridine derivatives
11/05/2003EP1358186A1 Laulimalide derivatives
11/05/2003EP1358184A1 Substituted alkylamine derivatives and methods of use
11/05/2003EP1358183A2 Cysteine protease inhibitors
11/05/2003EP1358182A1 Diazocine derivatives and their use as tryptase inhibitors
11/05/2003EP1358180A2 Naphthostyril derivatives and their use as inhibitors of cyclin-dependent kinases
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358172A2 Amino ceramide-like compounds and therapeutic methods of use
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/05/2003EP1358169A2 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase
11/05/2003EP1358168A1 Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitors
11/05/2003EP1358162A1 Dihydroindole and tetrahydroquinoline derivatives
11/05/2003EP1358161A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
11/05/2003EP1358155A1 Aromatic sulfonyl alpha-cycloamino hydroxamates and their use as mmp inhibitors
11/05/2003EP1357944A2 Perylenequinones for use with immunotherapy agents
11/05/2003EP1357935A2 Method of reducing side effects of chemotherapy in cancer patients
11/05/2003EP1357930A2 Histidine-rich glycoprotein
11/05/2003EP1357929A2 Modulation of immune response and methods based thereon
11/05/2003EP1357925A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use
11/05/2003EP1357921A2 Bacterial isolates from organisms that respire at least partially through their skin and biologically active extracts derived therefrom
11/05/2003EP1357915A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO 4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/05/2003EP1357909A1 Il-8 receptor antagonists
11/05/2003EP1357908A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
11/05/2003EP1357904A2 Use of pyrazolo 4,3-d]pyrimidines
11/05/2003EP1357903A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO b]THIOPHENE AND SALTS THEREOF
11/05/2003EP1357900A2 Process for production of nanoparticles and microparticles by spray freezing into liquid
11/05/2003EP1268480B1 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
11/05/2003EP1220858B1 Oxazinoquinolones useful for the treatment of viral infections
11/05/2003EP1178960B1 Vitamin d analogues and their pharmaceutical use
11/05/2003EP1140113B1 Use of bisphosphonates for the prevention and treatment of infectious processes
11/05/2003EP1105141B1 Phosphatidylcholine as a medicament for the protection of mucosa
11/05/2003EP1082298B1 1-alpha-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
11/05/2003EP1054857B1 Biaryl-acetic acid derivatives and their use as cox-2 inhibitors
11/05/2003EP1037670B1 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases
11/05/2003EP1009436B1 Acridine derivative for increasing the oral bioavailability of taxol
11/05/2003EP0989985B1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors
11/05/2003EP0960197A4 GENES FROM 20q13 AMPLICON AND THEIR USES
11/05/2003EP0946566B1 Pro-drugs and counterparts of camptothecin, their application as medicines
11/05/2003EP0871432B1 Use of a composition containing polyether block copolymers
11/05/2003CN1454254A Purging of cells using viruses
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454213A Variants of allergenic proteins of the Group2 of dermatophagoides
11/05/2003CN1454210A 嘧啶衍生物 Pyrimidine derivatives
11/05/2003CN1454099A Dendrimer-photosensitizer complexes for medical applications
11/05/2003CN1454098A Depletion method of blood plasma ascorbate
11/05/2003CN1454094A Minari extract for preventing the induction and metast asis of cancer by carcinogens contained in cigarette smoke, fermented foods or alcoholic drinks
11/05/2003CN1454091A Immunostimulatory nucleic acids
11/05/2003CN1454083A Selective androgen receptor modulators and methods for their identification design and use
11/05/2003CN1453361A Construction method of virus as anticancer targeting adjustable gene
11/05/2003CN1453001A Chinese medicine bolus for treating leukemia and its compounding process
11/05/2003CN1452970A Anticancer application of 2-methoxy estradiol, Neomycin sulfate and their mixture
11/05/2003CN1452960A Garcinolic acid injection and its prepn
11/05/2003CN1126743C Substituted quinazoline derivatives
11/05/2003CN1126566C Luteinizing hormone releasing hormone antagonist and use for medicine preparation for treating prostate hypertrophy and prostate cancer
1 ... 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 ... 2211